Mark Plavsic is Chief Technical Officer of FATE THERAPEUTICS INC. Currently has a direct ownership of 123,705 shares of FATE, which is worth approximately $205,350. The most recent transaction as insider was on Jan 10, 2023, when has been sold 3,418 shares (Common Stock) at a price of $5.24 per share, resulting in proceeds of $17,910. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K
0% 3M change
0% 12M change
Total Value Held $205,350

Mark Plavsic Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2023
SELL
Open market or private sale
$17,910 $5.24 p/Share
3,418 Reduced 2.69%
123,705 Common Stock
Jul 05 2022
SELL
Open market or private sale
$91,525 $24.61 p/Share
3,719 Reduced 2.84%
127,123 Common Stock
Jan 25 2022
BUY
Grant, award, or other acquisition
-
33,302 Added 20.29%
130,842 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
-
59,540 Added 37.9%
97,540 Common Stock
Jun 14 2021
BUY
Grant, award, or other acquisition
-
38,000 Added 50.0%
38,000 Common Stock

Also insider at

AURA
Aura Biosciences, Inc. Healthcare
MP

Mark Plavsic

Chief Technical Officer
San Diego, CA

Track Institutional and Insider Activities on FATE

Follow FATE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE